Prospect Venture Partners

Amicus Therapeutics is a biotechnology company focused on developing advanced therapies to treat a range of human genetic diseases.

#Biotechnology

Acquired by Bristol-Myers Squibb for $325 million.

#Pharmaceuticals

Aveo Oncology is focused on developing targeted therapies for cancer.

#Oncology

Acquired by Merz Pharma Group for $600 million.

#Aesthetics

Acquired by Merit Medical Systems.

#Medical Devices

Acquired by Celgene Corporation.

#Pharmaceuticals

Hansen Medical develops medical robotics for accurate positioning, manipulation, and control of catheters and catheter-based technologies.

#Medical Devices

Acquired by Pfizer.

#Pharmaceuticals

Infinity Pharmaceuticals is focused on discovering, developing, and delivering medicines for difficult-to-treat diseases.

#Pharmaceuticals

Insmed is a global biopharmaceutical company focused on the unmet needs of patients with rare diseases.

#Biotechnology

Jazz Pharmaceuticals is focused on developing and commercializing pharmaceutical products that address unmet medical needs.

#Pharmaceuticals

Acquired by Allergan for $2.1 billion.

#Biopharmaceuticals

Nanosys is a leader in developing and manufacturing quantum dot technology for displays.

#Nanotechnology

Acquired by C.R. Bard for $140 million.

#Medical Devices

NGM Bio is focused on discovering and developing novel therapeutics for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases.

#Biopharmaceuticals

NinePoint Medical is pioneering the use of advanced imaging technologies for the diagnosis and treatment of disease.

#Medical Devices

Novavax is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases.

#Biotechnology

Acquired by Cytyc Corporation for $325 million.

#Medical Devices

Acquired by ArthroCare Corporation for $130 million.

#Medical Devices

Panmira Pharmaceuticals focuses on the development of anti-inflammatory drugs.

#Pharmaceuticals

Portola Pharmaceuticals is focused on the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation.

#Biopharmaceuticals

Acquired by Pfizer.

#Biotechnology

Senomyx is focused on using proprietary taste receptor-based assays and screening technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries.

#Biotechnology

SentreHEART is focused on developing minimally invasive technologies for the treatment of heart disease.

#Medical Devices

Acquired by Johnson & Johnson.

#Medical Devices

Acquired by Ipsen.

#Biopharmaceuticals

Topica Pharmaceuticals is focused on developing topical antifungal treatments.

#Pharmaceuticals

Acquired by Insmed Incorporated.

#Biotechnology

Acquired by Emergent BioSolutions.

#Biopharmaceuticals

Acquired by Abbott for $400 million.

#Medical Devices

Acquired by Allergan.

#Pharmaceuticals